Last reviewed · How we verify

Purified inactivated rabies vaccine

Sanofi Pasteur, a Sanofi Company · Phase 3 active Biologic

Purified inactivated rabies vaccine is a Vaccine Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently in Phase 3 development for Rabies post-exposure prophylaxis, Rabies pre-exposure prophylaxis in high-risk individuals. Also known as: Verorab®, Verorab.

Purified inactivated rabies vaccine stimulates the immune system to produce antibodies and cellular immunity against rabies virus, preventing infection after exposure.

Purified inactivated rabies vaccine stimulates the immune system to produce antibodies and cellular immunity against rabies virus, preventing infection after exposure. Used for Rabies post-exposure prophylaxis, Rabies pre-exposure prophylaxis in high-risk individuals.

At a glance

Generic namePurified inactivated rabies vaccine
Also known asVerorab®, Verorab
SponsorSanofi Pasteur, a Sanofi Company
Drug classVaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhasePhase 3

Mechanism of action

The vaccine contains inactivated (killed) rabies virus particles that trigger both humoral (antibody) and cell-mediated immune responses without causing disease. Upon exposure to rabies virus, the pre-existing immunity provides rapid neutralization of the virus before it can reach the central nervous system. This is typically administered post-exposure in combination with rabies immunoglobulin for non-vaccinated individuals, or as pre-exposure prophylaxis for high-risk populations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Purified inactivated rabies vaccine

What is Purified inactivated rabies vaccine?

Purified inactivated rabies vaccine is a Vaccine drug developed by Sanofi Pasteur, a Sanofi Company, indicated for Rabies post-exposure prophylaxis, Rabies pre-exposure prophylaxis in high-risk individuals.

How does Purified inactivated rabies vaccine work?

Purified inactivated rabies vaccine stimulates the immune system to produce antibodies and cellular immunity against rabies virus, preventing infection after exposure.

What is Purified inactivated rabies vaccine used for?

Purified inactivated rabies vaccine is indicated for Rabies post-exposure prophylaxis, Rabies pre-exposure prophylaxis in high-risk individuals.

Who makes Purified inactivated rabies vaccine?

Purified inactivated rabies vaccine is developed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).

Is Purified inactivated rabies vaccine also known as anything else?

Purified inactivated rabies vaccine is also known as Verorab®, Verorab.

What drug class is Purified inactivated rabies vaccine in?

Purified inactivated rabies vaccine belongs to the Vaccine class. See all Vaccine drugs at /class/vaccine.

What development phase is Purified inactivated rabies vaccine in?

Purified inactivated rabies vaccine is in Phase 3.

What are the side effects of Purified inactivated rabies vaccine?

Common side effects of Purified inactivated rabies vaccine include Injection site reactions (pain, erythema, swelling), Headache, Myalgia, Fever, Nausea.

Related